41. New method for immunoprofiling of the tumor microenvironment of cancer patients by opal multiplex quantitative immunofluorescence (IF) assay. (4th November 2015) Authors: Kallinteris, Nikoletta L; Shan, Joseph; Meyer, Jeffrey; Yopp, Adam C; Frankel, Athur; Downing, Sean R; Robertson, Brenda S; Hoyt, Cliff; King, Steven; Bifulco, Carlo; Ballesteros-Merino, Carmen; Fox, Bernard Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
42. New method for immunoprofiling of the tumor microenvironment of cancer patients by opal multiplex quantitative immunofluorescence (IF) assay. Issue 2 (December 2015) Authors: Kallinteris, Nikoletta; Shan, Joseph; Meyer, Jeffrey; Yopp, Adam; Frankel, Athur; Downing, Sean; Robertson, Brenda; Hoyt, Cliff; King, Steven; Bifulco, Carlo; Ballesteros-Merino, Carmen; Fox, Bernard Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
43. Novel technologies and emerging biomarkers for personalized cancer immunotherapy. Issue 1 (December 2016) Authors: Yuan, Jianda; Hegde, Priti; Clynes, Raphael; Foukas, Periklis; Harari, Alexandre; Kleen, Thomas; Kvistborg, Pia; Maccalli, Cristina; Maecker, Holden; Page, David; Robins, Harlan; Song, Wenru; Stack, Edward; Wang, Ena; Whiteside, Theresa; Zhao, Yingdong; Zwierzina, Heinz; Butterfield, Lisa; Fox, B... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
44. Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge", Napoli, December 5th 2015. Issue 1 (December 2016) Authors: Ascierto, Paolo; Ascierto, Maria; Formenti, Silvia; Gnjatic, Sacha; Hammers, Hans; Hirsh, Vera; Kiessling, Rolf; Melero, Ignacio; Nanda, Rita; Pawelec, Graham; Pignata, Sandro; Romero, Pedro; Speiser, Daniel; Fox, Bernard; Marincola, Francesco Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
45. Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment. (4th November 2015) Authors: Andtbacka, Robert HI; Curti, Brendan D; Hallmeyer, Sigrun; Feng, Zipei; Paustian, Christopher; Bifulco, Carlo; Fox, Bernard; Grose, Mark; Shafren, Darren Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
46. Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment. Issue 2 (December 2015) Authors: Andtbacka, Robert; Curti, Brendan; Hallmeyer, Sigrun; Feng, Zipei; Paustian, Christopher; Bifulco, Carlo; Fox, Bernard; Grose, Mark; Shafren, Darren Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
47. Preamble to the 2015 SITC immunotherapy biomarkers taskforce. Issue 1 (December 2015) Authors: Butterfield, Lisa; Disis, Mary; Fox, Bernard; Khleif, Samir; Marincola, Francesco Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
48. Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC. Issue 2 (December 2015) Authors: Sanborn, Rachel; Boulmay, Brian; Li, Rui; Spieler, Bradley; Happel, Kyle; Paustian, Christopher; Mougdil, Tarsem; Feng, Zipei; Dubay, Christopher; Fisher, Brenda; Koguchi, Yoshinobu; Aung, Sandra; Mederos, Eileen; Bifulco, Carlo; McNamara, Michael; Bahjat, Keith; Redmond, William; Ochoa, Augusto;... Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
49. Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC. (4th November 2015) Authors: Sanborn, Rachel; Boulmay, Brian; Li, Rui; Spieler, Bradley; Happel, Kyle; Paustian, Christopher; Mougdil, Tarsem; Feng, Zipei; Dubay, Christopher; Fisher, Brenda; Koguchi, Yoshinobu; Aung, Sandra; Mederos, Eileen; Bifulco, Carlo; McNamara, Michael; Bahjat, Keith S; Redmond, William; Ochoa, August... Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
50. Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC. (6th November 2014) Authors: Hilton, Traci; Sanborn, Rachel; Boulmay, Brian; Li, Rui; Spieler, Bradley; Happel, Kyle; Paustian, Christopher; Moudgil, Tarsem; Dubay, Christopher; Fisher, Brenda; Mederos, Eileen; Ochoa, Augusto; Urba, Walter J; Hu, Hong-Ming; Fox, Bernard Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗